All Posts: cancer
-
Small Numbers of Cells in a Tumor Could Be Key Enablers of Cancer Metastasis
WASHINGTON (June 16, 2021) — Just a small number of cells found in tumors can enable and recruit other types of cells nearby, allowing the cancer to spread to other parts of the body, report Georgetown Lombardi Comprehensive Cancer Center scientists. Working with their research collaborators, the scientists found that “enabler cells” comprise about 20 […]
Category: News Release
-
Clinical Trial Result Leads to New Treatment Option for Hard-to-Treat Breast Cancer
(June 4, 2021) — A clinical trial exploring a new treatment for breast cancer found that women with a hard-to-treat form of the disease lived longer without the disease coming back following treatment. The trial was conducted at sites around the world, including Georgetown Lombardi Comprehensive Cancer Center. “This finding represents a significant step forward […]
Category: Lombardi Stories
-
From Husband and Wife to Caregiver and Patient, John and Liza Marshall Reflect on Their Personal Cancer Journey in New Memoir
(April 15, 2021) — As the current chief of the Division of Hematology/Oncology at Georgetown Lombardi and the director of The Ruesch Center for the Cure of Gastrointestinal Cancers, John Marshall, MD, said that the hardest yet most important job of his life was taking on the role of caregiver when his wife Liza was […]
Category: Lombardi Stories
-
Renowned Georgetown Cancer and Aging Researcher Receives Top Honor in Her Field
(March 28, 2021) — When Jeanne Mandelblatt, MD, PhD, MPH, reflects on the arc of her research career, she sees no single standout moment that cemented her path. Instead, the revered member of Georgetown Lombardi Comprehensive Cancer Center and professor of oncology and medicine at Georgetown attributes her distinguished career to a continuum of work […]
Category: Special Stories
-
Music to Our Ears: Georgetown Lombardi’s Arts & Humanities Program Receives National Endowment for the Arts Grant
(February 14, 2021) — In February, the Georgetown Lombardi Arts & Humanities Program (AHP) was awarded a grant from the National Endowment for the Arts (NEA) to study the effect of music on ICU patients’ neurologic and physiologic responses. The award appears to be the first time GUMC has received research funding from the NEA. […]
Category: Lombardi Stories
-
Mechanism for How Pancreatic Cancer Evades Immunotherapy Elucidated
Discovery could lead to new or improved therapeutic options. WASHINGTON (January 28, 2021) — Pancreatic cancer, one of the most lethal of all cancers, is capable of evading attacks by immune cells by changing its microenvironment so that the immune cells suppress, rather than support, an attack on the tumor, according to a study led […]
Category: News Release
-
Glynda’s Story: A Chance to Advance Treatment for Aggressive Cancer
(January 11, 2021) — Inspired by the kindness, proficiency and dedication of her health care team at Georgetown Lombardi Comprehensive Cancer Center, Glynda Brown, a 52-year-old Maryland resident, felt determined to “pay it forward” and make a positive difference for future patients by participating in a clinical trial after she was diagnosed with triple-negative breast […]
Category: Lombardi Stories
-
Georgetown Lombardi Oncologists Encourage Patients to Keep Up with Cancer Screenings
(November 20, 2020) — If you’re due for a routine cancer screening test, you should contact your doctor to find out if it can be safely deferred until the risk of COVID-19 goes down. In contrast, if you have symptoms that could be a sign of cancer, don’t delay and don’t let the pandemic discourage […]
Category: Lombardi Stories
-
Analyzing Tumors in Real Time to Detect Metastatic Cells Could Aid in Treatment
(November 12, 2020) — Identifying cells that metastasize from the primary tumor to other sites in the body, thereby expanding their lethality, has been a goal of scientists for years. If researchers knew more about what gives metastatic cells their ability to spread and grow throughout the body, there would be a better chance to […]
Category: Lombardi Stories
-
Immunotherapy Combo Halts Rare, Stage 4 Sarcoma in Teen
NUTLEY, NJ (October 14, 2020) — A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment had a “rapid and complete response” to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center […]
Category: News Release